SEARCH

SEARCH BY CITATION

References

  • 1
    Uyttenhove, C., Simpson, R. and Van Snick, J., Functional and structural characterization of P40, a mouse glycoprotein with T cell growth factor activity. Proc. Natl. Acad. Sci. USA 1988. 85: 69346938.
  • 2
    Schmitt, E., van Brandwijk, R., Van Snick, J., Siebold, B. and Rüde, E., TCGF III/P40 is produced by naive murine CD4+T cells but is not a general T cell growth factor. Eur. J. Immunol. 1989. 19: 21672170.
  • 3
    Hültner, L., Druez, C., Moeller, J., Uyttenhove, C., Schmitt, E., Rüde, E., Dörmer, P. and Van Snick, J., Mast cell growth enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin-9). Eur. J. Immunol. 1990. 20: 14131416.
  • 4
    Richard, M., Grencis, R. K., Humphreys, N. E., Renauld, J.-C. and Van Snick, J., Anti-IL-9 vaccination prevents worm expulsion and blood eosinophilia in Trichuris muris-infected mice. Proc. Natl. Acad. Sci. USA 2000. 97: 767772.
  • 5
    Townsend, J. M., Fallon, G. P., Matthews, J. D., Smith, P., Jolin, E. H. and McKenzie, N. A., IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity 2000. 13: 573583.
  • 6
    Else, K. J., Hultner, L. and Grencis, R. K., Cellular immune responses to the murine nematode parasite Trichuris muris. II. Differential induction of TH-cell subsets in resistant versus susceptible mice. Immunology 1992. 75: 232237.
  • 7
    Gessner, A., Blum, H. and Rollinghoff, M., Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice. Immunobiology 1993. 189: 419435.
  • 8
    Gounni, A. S., Nutku, E., Koussih, L., Aris, F., Louahed, J., Levitt, R. C., Nicolaides, N. C. and Hamid, Q., IL-9 expression by human eosinophils: regulation by IL-1beta and TNF-alpha. J. Allergy Clin. Immunol. 2000. 106: 460466.
  • 9
    Veldhoen, M., Uyttenhove, C., van Snick, J., Helmby, H., Westendorf, A., Buer, J., Martin, B. et al., Transforming growth factor-beta ‘reprograms’ the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 2008. 9: 13411346.
  • 10
    Dardalhon, V., Awasthi, A., Kwon, H., Galileos, G., Gao, W., Sobel, R. A., Mitsdoerffer, M. et al., IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(−) effector T cells. Nat. Immunol. 2008. 9: 13471355.
  • 11
    Schmitt, E., Germann, T., Goedert, S., Hoehn, P., Huels, C., Koelsch, S., Kühn, R. et al., IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-β and IL-4, and is inhibited by IFNg. J. Immunol. 1994. 153: 39893996.
  • 12
    Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L. and Kuchroo, V. K., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006. 441: 235238.
  • 13
    Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D. et al., Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006. 441: 231234.
  • 14
    Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M. and Stockinger, B., TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006. 24: 179189.
  • 15
    Elyaman, W., Bradshaw, E. M., Uyttenhove, C., Dardalhon, V., Awasthi, A., Imitola, J., Bettelli, E. et al., IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. Proc. Natl. Acad. Sci. USA 2009. 106: 1288512890.
  • 16
    Nowak, E. C., Weaver, C. T., Turner, H., Begum-Haque, S., Becher, B., Schreiner, B., Coyle, A. J. et al., IL-9 as a mediator of Th17-driven inflammatory disease. J. Exp. Med. 2009. 206: 16531660.
  • 17
    Helmby, H. and Grencis, R. K., Interleukin 1 plays a major role in the development of Th2-mediated immunity. Eur. J. Immunol. 2004. 34: 36743681.
  • 18
    Humphreys, N. E. and Grencis, R. K., IL-1-dependent, IL-1R1-independent resistance to gastrointestinal nematodes. Eur. J. Immunol. 2009. 39: 10361045.
  • 19
    Von Stebut, E., Ehrchen, J. M., Belkaid, Y., Kostka, S. L., Molle, K., Knop, J., Sunderkotter, C. and Udey, M. C., Interleukin 1alpha promotes Th1 differentiation and inhibits disease progression in Leishmania major-susceptible BALB/c mice. J. Exp. Med. 2003. 198: 191199.
  • 20
    Schmitt, E., Beuscher, U., Huels, C., Monteyne, P., Van Brandwijk, R., Van Snick, J. and Ruede, E., IL-1 serves as a secondary signal for IL-9 expression. J. Immunol. 1991. 147: 38483854.
  • 21
    Laurence, A., Tato, C. M., Davidson, T. S., Kanno, Y., Chen, Z., Yao, Z., Blank, R. B. et al., Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007. 26: 371381.
  • 22
    Sutton, C., Brereton, C., Keogh, B., Mills, K. H. and Lavelle, E. C., A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 2006. 203: 16851691.
  • 23
    Murphy, K. M., Heimberger, A. B. and Loh, D. Y., Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science 1990. 250: 17201723.
  • 24
    Noben-Trauth, N., Kohler, G., Burki, K. and Ledermann, B., Efficient targeting of the IL-4 gene in a BALB/c embryonic stem cell line. Transgenic Res. 1996. 5: 487491.
  • 25
    Billiau, A., Heremans, H., Vandekerckhove, F. and Dillen, C., Anti-interferon-gamma antibody protects mice against the generalized Shwartzman reaction. Eur. J. Immunol. 1987. 17: 18511854.